DK1349541T3 - Selvemulgerende lipidmatrix (SELM) - Google Patents

Selvemulgerende lipidmatrix (SELM)

Info

Publication number
DK1349541T3
DK1349541T3 DK01270324T DK01270324T DK1349541T3 DK 1349541 T3 DK1349541 T3 DK 1349541T3 DK 01270324 T DK01270324 T DK 01270324T DK 01270324 T DK01270324 T DK 01270324T DK 1349541 T3 DK1349541 T3 DK 1349541T3
Authority
DK
Denmark
Prior art keywords
selm
self
lipid matrix
emulsifying lipid
emulsifying
Prior art date
Application number
DK01270324T
Other languages
English (en)
Inventor
Dieter Roethlisberger
Martin Kuentz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1349541T3 publication Critical patent/DK1349541T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01270324T 2000-12-14 2001-12-08 Selvemulgerende lipidmatrix (SELM) DK1349541T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00127414 2000-12-14

Publications (1)

Publication Number Publication Date
DK1349541T3 true DK1349541T3 (da) 2007-01-08

Family

ID=8170664

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01270324T DK1349541T3 (da) 2000-12-14 2001-12-08 Selvemulgerende lipidmatrix (SELM)

Country Status (17)

Country Link
US (1) US6719996B2 (da)
EP (1) EP1349541B1 (da)
JP (1) JP4116436B2 (da)
KR (1) KR100602299B1 (da)
CN (1) CN1263446C (da)
AR (1) AR032783A1 (da)
AT (1) ATE341311T1 (da)
AU (2) AU2002216085B8 (da)
BR (1) BRPI0116121B8 (da)
CA (1) CA2431397C (da)
DE (1) DE60123661T2 (da)
DK (1) DK1349541T3 (da)
ES (1) ES2272408T3 (da)
MX (1) MXPA03005169A (da)
PT (1) PT1349541E (da)
WO (1) WO2002047663A1 (da)
ZA (1) ZA200304263B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
CA2572645C (en) 2004-07-06 2011-01-18 F. Hoffmann-La Roche Ag Process for preparing carboxamide derivatives used as intermediates in the synthesis of nk-1 receptor antagonists
CN101128189A (zh) 2005-02-25 2008-02-20 弗·哈夫曼-拉罗切有限公司 药物物质分散性改善的片剂
US20070104780A1 (en) * 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
CN104856999A (zh) 2009-11-18 2015-08-26 赫尔辛医疗股份公司 用于治疗中枢介导的恶心及呕吐的组合物及方法
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
JP2014530249A (ja) 2011-10-18 2014-11-17 ヘルシン ヘルスケア ソシエテ アノニム ネツピタントおよびパロノセトロンの治療学的組合せ
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
WO2016136806A1 (ja) * 2015-02-26 2016-09-01 日清オイリオグループ株式会社 チョコレート用粉末油脂組成物
US20180250270A1 (en) 2015-09-11 2018-09-06 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CA3059418A1 (en) 2017-04-10 2018-10-18 Chase Therapeutics Corporation Nk1-antagonist combination and method for treating synucleinopathies
MX2019015150A (es) 2017-06-30 2020-08-13 Chase Therapeutics Corp Composiciones antagonistas de nk-1 y métodos para su uso en el tratamiento de la depresión.
CN109200018A (zh) * 2017-07-04 2019-01-15 南京诺瑞特医药科技有限公司 含有奈妥吡坦的微乳制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
SI1035115T1 (en) * 1999-02-24 2005-02-28 F. Hoffmann-La Roche Ag 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
EP1349541B1 (en) 2006-10-04
PT1349541E (pt) 2007-01-31
WO2002047663A1 (en) 2002-06-20
DE60123661T2 (de) 2007-08-16
JP2004517837A (ja) 2004-06-17
BRPI0116121B1 (pt) 2015-07-14
CN1263446C (zh) 2006-07-12
CN1514720A (zh) 2004-07-21
KR100602299B1 (ko) 2006-07-14
MXPA03005169A (es) 2003-09-22
KR20030062423A (ko) 2003-07-25
AU1608502A (en) 2002-06-24
ATE341311T1 (de) 2006-10-15
CA2431397C (en) 2007-05-01
US6719996B2 (en) 2004-04-13
AU2002216085B2 (en) 2005-11-03
AU2002216085B8 (en) 2006-03-02
JP4116436B2 (ja) 2008-07-09
US20020114837A1 (en) 2002-08-22
ES2272408T3 (es) 2007-05-01
BR0116121A (pt) 2003-10-14
CA2431397A1 (en) 2002-06-20
EP1349541A1 (en) 2003-10-08
ZA200304263B (en) 2004-03-26
BRPI0116121B8 (pt) 2021-05-25
DE60123661D1 (de) 2006-11-16
AR032783A1 (es) 2003-11-26

Similar Documents

Publication Publication Date Title
DE60129488D1 (de) Anzeigegerät
DE60141864D1 (de) Tragbares Anzeigesystem
DE60131208D1 (de) Tragbares Anzeigesystem
DK1349541T3 (da) Selvemulgerende lipidmatrix (SELM)
DE60143037D1 (de) Gleitlager
DE60105365D1 (de) Matrixanzeigegerät
DE60138669D1 (de) Sicherungseinheit
FR2810866B1 (fr) Presentoir
DE60116214D1 (de) Mechanischer Brecher
DE50109128D1 (de) Einlegesohle
DE60042344D1 (de) Bordeigenes anzeigesystem
NO20001294D0 (no) Måler for skyvekraft
DE60117455T8 (de) Sicherungseinheit
DE50107617D1 (de) Bedieneinheit
DE50108726D1 (de) Elastomerlager
NO20025628D0 (no) Overlevelseshjelp
FI20002248A0 (fi) Eristysmoduli
DE60038397D1 (de) Plattengerät
DE50111524D1 (de) Namensschildhülle
DE60119481D1 (de) Baugruppe
DE50105745D1 (de) Anzeigeeinrichtung
DE60134536D1 (de) Matrix-aktor
ATA17592000A (de) Werbeträger
UA4169S (uk) Комп`ютер
SE0004500D0 (sv) Skyltar